Home
Duchenne
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
Search
About Us
Contact
Privacy Policy
type here...
Search
Instagram
Facebook
Twitter
Bluesky
Home
Duchenne
Duchenne MD
What is Duchenne?
Genetic Causes
Creatine Kinase (CK)
Genetic Testing
Prenatal Testing
Becker MD
DMD vs BMD
NSAA Assessment
Genetic
Genetic Counseling
Exon Check Tool
Dystrophin Gene
Genetic Variants
Exon Deletion
Duchenne Carriers
Nucleotides in DMD
Isoforms in DMD
Care Guidelines
Newly Diagnosed
Neuromuscular Team
Respiratory Devices
BiPAP Machine
Ankle Foot Orthosis
Rhabdomyolysis
Power Wheelchair
Traveling with DMD
Health Guidelines
Psychological Support in DMD
Nutrition in DMD
Nutraceuticals
Respiratory Health
Dental Health
Surgery & Anesthesia
Swallowing Difficulty
Steroids (Cortisone)
Categories
Care Guidelines
Press Releases
Approved Therapies
Researches
Editorials
Family Stories
Clinical Trials
WhatsAPP
Facebook
Instagram
X
Youtube
Latest Posts
Research
DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD
Care Guidelines
What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?
Care Guidelines
Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage
Articles by:
DMD Warrior
Press Releases
Sarepta Reported 3-Year Topline Data of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy
Press Releases
Atossa Therapeutics Receives FDA Orphan Drug Designation for (Z)-Endoxifen for the Treatment of Duchenne Muscular Dystrophy
Press Releases
AGAMREE (Vamorolone) has been approved in Switzerland by Swissmedic
Press Releases
Solid Biosciences Announces 2026 Outlook for Clinical Trials of Duchenne Gene Therapy SGT-003
Press Releases
Edgewise Therapeutics Shared its Priorities for Becker and Duchenne Muscular Dystrophy in 2026
Press Releases
Precision BioSciences Anticipates Beginning Patient Dosing for Duchenne Muscular Dystrophy in The Early Second Quarter of 2026
Press Releases
Entrada Therapeutics Announced It will Report Data from its Exon Skipping Studies in 2026
Press Releases
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
1
...
12
13
14
...
46
Page 13 of 46
Latest Posts
Research
DYNE-251 Phase 3 FORZETTO Clinical Trial of Z-Rostudirsen Officially Begins for DMD
Care Guidelines
What Is a Spirometry Test in Duchenne Muscular Dystrophy (DMD) and Why Is It Performed?
Care Guidelines
Age-Based Assistive Devices for Duchenne Muscular Dystrophy: Complete Guide by Stage
Research
Del-Zota SAFARI44 Phase 3 Trial: A New Exon 44 Skipping Study for Duchenne Muscular Dystrophy
Don't Miss
DMD
Investigational New Drug (IND) Clearance for Duchenne Muscular Dystrophy: Process, Trials & Future Therapies
Editorials
Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy
Care Guidelines
Hydrotherapy in Duchenne Muscular Dystrophy (DMD): Benefits, Exercises, and Clinical Evidence
Care Guidelines
Newly Diagnosed Patients with Duchenne Muscular Dystrophy: A Complete Family Guide
Press Releases
New Hope for Duchenne: Ryoncil Clinical Trial Begins
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language
Close and do not switch language
We've detected you might be speaking a different language. Do you want to change to:
English
English
Português do Brasil
Deutsch
Français
Español
Русский
العربية
हिन्दी
简体中文
Türkçe
Change Language